Unveiling the ‘Zombie Drug’ Threat: Xylazine’s Deadly Rise in U.S. Drug Scene

Unveiling the ‘Zombie Drug’ Threat: Xylazine's Deadly Rise in U.S. Drug Scene
Unveiling the ‘Zombie Drug’ Threat: Xylazine's Deadly Rise in U.S. Drug Scene
Share on social

The DEA is raising alarms over the rising presence of a lethal horse tranquilizer, Xylazine, on U.S. streets. Known as the ‘zombie drug,’ Xylazine causes disturbing physical and potentially fatal effects when abused, and has been detected in cities such as San Francisco, Philadelphia, and New York. It’s often mixed with fentanyl to heighten users’ high, creating a deadly cocktail. The DEA reports Xylazine was present in 23% of fentanyl powder and 7% of fentanyl pills seized in 2022. Alarmingly, overdose reversal drugs prove ineffective against Xylazine due to its non-opioid nature. Despite its life-threatening effects, Xylazine isn’t federally controlled, enabling wider accessibility. Efforts are underway to reclassify it as a Schedule III drug.

Next News Network Team

Next News Network Team

Stay Updated

Get us in your inbox

By subscribing you agree to our Privacy Policy

New & Trending
Latest Videos
sponsored
Follow us
Related Articles